SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Sigyn Therapeutics, Inc.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $48.16K
- P/E (TTM)
- –
- Dividend yield
- –
Sigyn Therapeutics, Inc. revenue by segment
By business segment
| Revenue | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|
| Wholesale Sales [Member] | $143.32K | $63.98K | $222.93K | 100.0% | +124.0% |
| Retail sales [Member] | $0 | $623.51K | $1.06M | 0.0% | -100.0% |
By product or service
By region
From the segment and revenue-disaggregation notes of Sigyn Therapeutics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.